PBYI
Puma Biotechnology, Inc.
NASDAQ · USHealthcareBiotechnology
$8.30-2.70%
Price as of Jul 20, 2026
PBYI valuation
Puma Biotechnology, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 21.84x
- P/E 2026E
- 32.70x
- P/E 2027E
- 16.35x
- P/E 2028E
- 18.17x
- P/S forward
- 3.41x
Trailing multiples
- P/E TTM
- 16.73x
- PEG TTM
- 0.08x
- Price / book
- 3.29x
- Price / sales
- 1.86x
- Price / cash flow
- 7.88x
Enterprise value
- Enterprise value
- $336.9M
- EV / sales
- 1.48x
- EV / EBITDA
- 7.50x
- EV / EBIT
- 11.42x
- Market cap
- $422.5M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.